Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Rebecca L. Klank; Stacy A. Decker Grunke; Benjamin L. Bangasser; Colleen L. Forster; Matthew A. Price; Thomas J. Odde; Karen S. SantaCruz; Steven S. Rosenfeld; Peter Canoll; Eva A. Turley; James B. McCarthy; John R. Ohlfest; David J. Odde

doi:10.1016/j.celrep.2016.12.024

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Rebecca L. Klank, Stacy A. Decker Grunke, Benjamin L. Bangasser, Colleen L. Forster, Matthew A. Price, Thomas J. Odde, Karen S. SantaCruz, Steven S. Rosenfeld, Peter Canoll, Eva A. Turley, James B. McCarthy, John R. Ohlfest, David J. Odde

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Abstract

While several studies link the cell-surface marker CD44 to cancer progression, conflicting results show both positive and negative correlations with increased CD44 levels. Here, we demonstrate that the survival outcomes of genetically induced glioma-bearing mice and of high-grade human glioma patients are biphasically correlated with CD44 level, with the poorest outcomes occurring at intermediate levels. Furthermore, the high-CD44-expressing mesenchymal subtype exhibited a positive trend of survival with increased CD44 level. Mouse cell migration rates in ex vivo brain slice cultures were also biphasically associated with CD44 level, with maximal migration corresponding to minimal survival. Cell simulations suggest that cell-substrate adhesiveness is sufficient to explain this biphasic migration. More generally, these results highlight the potential importance of non-monotonic relationships between survival and biomarkers associated with cancer progression.

Original language	English (US)
Pages (from-to)	23-31
Number of pages	9
Journal	Cell reports
Volume	18
Issue number	1
DOIs	https://doi.org/10.1016/j.celrep.2016.12.024
State	Published - Jan 3 2017

Bibliographical note

Funding Information:
The study was supported by U.S. NIH grants RC1-CA145044 and R01-CA172986 to D.J.O. and S.R.R.; a University of Minnesota Institute for Engineering in Medicine Group grant to D.J.O.; U.S. NIH grant R01-CA138437; American Cancer Society grant RSG-09-189-01-LIB; the State of Minnesota, Minnesota Partnership for Biotechnology and Medical Genomics, and Children's Cancer Research Fund to J.R.O.; U.S. NIH grants T32-GM008471, T32-DA022616, and F31-NS67937 to S.A.D.; National Science Foundation Graduate Research Fellowship 00006595 to B.L.B.; and the Minnesota Supercomputing Institute.

Publisher Copyright:
© 2017 The Authors

Keywords

CD44
biphasic migration
biphasic survival
glioma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.celrep.2016.12.024

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498149

Find It

Find It at U of M Libraries

Cite this

Klank, R. L., Decker Grunke, S. A., Bangasser, B. L., Forster, C. L., Price, M. A., Odde, T. J., SantaCruz, K. S., Rosenfeld, S. S., Canoll, P., Turley, E. A., McCarthy, J. B., Ohlfest, J. R., & Odde, D. J. (2017). Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level. Cell reports, 18(1), 23-31. https://doi.org/10.1016/j.celrep.2016.12.024

@article{4895a483d4a8444ab840c236c2eb3e64,

title = "Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level",

abstract = "While several studies link the cell-surface marker CD44 to cancer progression, conflicting results show both positive and negative correlations with increased CD44 levels. Here, we demonstrate that the survival outcomes of genetically induced glioma-bearing mice and of high-grade human glioma patients are biphasically correlated with CD44 level, with the poorest outcomes occurring at intermediate levels. Furthermore, the high-CD44-expressing mesenchymal subtype exhibited a positive trend of survival with increased CD44 level. Mouse cell migration rates in ex vivo brain slice cultures were also biphasically associated with CD44 level, with maximal migration corresponding to minimal survival. Cell simulations suggest that cell-substrate adhesiveness is sufficient to explain this biphasic migration. More generally, these results highlight the potential importance of non-monotonic relationships between survival and biomarkers associated with cancer progression.",

keywords = "CD44, biphasic migration, biphasic survival, glioma",

author = "Klank, {Rebecca L.} and {Decker Grunke}, {Stacy A.} and Bangasser, {Benjamin L.} and Forster, {Colleen L.} and Price, {Matthew A.} and Odde, {Thomas J.} and SantaCruz, {Karen S.} and Rosenfeld, {Steven S.} and Peter Canoll and Turley, {Eva A.} and McCarthy, {James B.} and Ohlfest, {John R.} and Odde, {David J.}",

note = "Funding Information: The study was supported by U.S. NIH grants RC1-CA145044 and R01-CA172986 to D.J.O. and S.R.R.; a University of Minnesota Institute for Engineering in Medicine Group grant to D.J.O.; U.S. NIH grant R01-CA138437; American Cancer Society grant RSG-09-189-01-LIB; the State of Minnesota, Minnesota Partnership for Biotechnology and Medical Genomics, and Children's Cancer Research Fund to J.R.O.; U.S. NIH grants T32-GM008471, T32-DA022616, and F31-NS67937 to S.A.D.; National Science Foundation Graduate Research Fellowship 00006595 to B.L.B.; and the Minnesota Supercomputing Institute. Publisher Copyright: {\textcopyright} 2017 The Authors",

year = "2017",

month = jan,

day = "3",

doi = "10.1016/j.celrep.2016.12.024",

language = "English (US)",

volume = "18",

pages = "23--31",

journal = "Cell Reports",

issn = "2211-1247",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

AU - Klank, Rebecca L.

AU - Decker Grunke, Stacy A.

AU - Bangasser, Benjamin L.

AU - Forster, Colleen L.

AU - Price, Matthew A.

AU - Odde, Thomas J.

AU - SantaCruz, Karen S.

AU - Rosenfeld, Steven S.

AU - Canoll, Peter

AU - Turley, Eva A.

AU - McCarthy, James B.

AU - Ohlfest, John R.

AU - Odde, David J.

N1 - Funding Information: The study was supported by U.S. NIH grants RC1-CA145044 and R01-CA172986 to D.J.O. and S.R.R.; a University of Minnesota Institute for Engineering in Medicine Group grant to D.J.O.; U.S. NIH grant R01-CA138437; American Cancer Society grant RSG-09-189-01-LIB; the State of Minnesota, Minnesota Partnership for Biotechnology and Medical Genomics, and Children's Cancer Research Fund to J.R.O.; U.S. NIH grants T32-GM008471, T32-DA022616, and F31-NS67937 to S.A.D.; National Science Foundation Graduate Research Fellowship 00006595 to B.L.B.; and the Minnesota Supercomputing Institute. Publisher Copyright: © 2017 The Authors

PY - 2017/1/3

Y1 - 2017/1/3

N2 - While several studies link the cell-surface marker CD44 to cancer progression, conflicting results show both positive and negative correlations with increased CD44 levels. Here, we demonstrate that the survival outcomes of genetically induced glioma-bearing mice and of high-grade human glioma patients are biphasically correlated with CD44 level, with the poorest outcomes occurring at intermediate levels. Furthermore, the high-CD44-expressing mesenchymal subtype exhibited a positive trend of survival with increased CD44 level. Mouse cell migration rates in ex vivo brain slice cultures were also biphasically associated with CD44 level, with maximal migration corresponding to minimal survival. Cell simulations suggest that cell-substrate adhesiveness is sufficient to explain this biphasic migration. More generally, these results highlight the potential importance of non-monotonic relationships between survival and biomarkers associated with cancer progression.

AB - While several studies link the cell-surface marker CD44 to cancer progression, conflicting results show both positive and negative correlations with increased CD44 levels. Here, we demonstrate that the survival outcomes of genetically induced glioma-bearing mice and of high-grade human glioma patients are biphasically correlated with CD44 level, with the poorest outcomes occurring at intermediate levels. Furthermore, the high-CD44-expressing mesenchymal subtype exhibited a positive trend of survival with increased CD44 level. Mouse cell migration rates in ex vivo brain slice cultures were also biphasically associated with CD44 level, with maximal migration corresponding to minimal survival. Cell simulations suggest that cell-substrate adhesiveness is sufficient to explain this biphasic migration. More generally, these results highlight the potential importance of non-monotonic relationships between survival and biomarkers associated with cancer progression.

KW - CD44

KW - biphasic migration

KW - biphasic survival

KW - glioma

UR - http://www.scopus.com/inward/record.url?scp=85009121704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009121704&partnerID=8YFLogxK

U2 - 10.1016/j.celrep.2016.12.024

DO - 10.1016/j.celrep.2016.12.024

M3 - Article

C2 - 28052252

AN - SCOPUS:85009121704

VL - 18

SP - 23

EP - 31

JO - Cell Reports

JF - Cell Reports

SN - 2211-1247

IS - 1

ER -

Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression Level

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this